SUPN : Analysis & Opinions

  1. Supernus ADHD Drug Trial Shows Good Results (SUPN)

    October 12, 2016
    Supernus Pharmaceuticals said mid-stage trials of its ADHD drug, SPN-812, showed good results. The company plans to launch ...
  2. Smaller Biotechs Surging to New Highs

    August 23, 2016
    Small- and mid-cap biotechs are attracting healthy buying interest and setting off bullish divergences that support higher ...
  3. 3 Biotech Stocks Headed for New Highs (SCLN, SUPN)

    June 3, 2016
    These biotech leaders should continue to gain ground even if broad sector funds roll over and sell off.